GMDA.Q Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
Gamida Cell Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
GMDA.Q Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Gamida Cell Ltd. Key Details
Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
- -0.40
- -241.92%
- -2,317.95%
- -401.0%
About GMDA.Q
- Founded
- 1998
- Employees
- 147
- CEO
- WebsiteView website
Gamida Cell Ltd. researches, develops, and commercializes cell therapies. The company offers Omisirge (omidubicel-onlv), a cell therapy for use in treatment of patients with hematologic malignancies and severe aplastic anemia. Its product candidate includes GDA-201, an investigational NK cell-based cancer immunotherapy, for the treatment of hematologic and solid tumors, as well as to treat follicular and diffuse large B-cell lymphomas which is in phase 1 of phase1/2 clinical trial. The company was incorporated in 1998 and is based in Boston, Massachusetts.
